A publication by scientists of the Anticancer Fund

Pancreatic resection with perioperative drug repurposing of propranolol and etodolac: trial protocol of the phase-II randomised placebo controlled PROSPER trial

Felix J Hüttner, Ilse Rooman, Gauthier Bouche, Phillip Knebel, Johannes Hüsing, André L Mihaljevic, Thilo Hackert, Oliver Strobel, Markus W Büchler, Markus K Diener. Pancreatic resection with perioperative drug repurposing of propranolol and etodolac: trial protocol of the phase-II randomised placebo controlled PROSPER trial. BMJ Journals, 2020 Sep 30;10(9):e040406, doi: 10.1136/bmjopen-2020-040406.
A publication by scientists of the Anticancer Fund

Predicting combinations of immunomodulators to enhance dendritic cell-based vaccination based on a hybrid experimental and computational platform

Rita Ahmed, Isaac Crespo, Sandra Tuyaerts, Amel Bekkar, Michele Graciotti, Ioannis Xenarios, Lana E. Kandalaft (2020). Predicting combinations of immunomodulators to enhance dendritic cell-based vaccination based on a hybrid experimental and computational platform. Computational and Structural Biotechnology Journal 18 (2020) 2217–2227, https://doi.org/10.1016/j.csbj.2020.08.001

"Strengthening Europe in the fight against cancer"

A publication by scientists of the Anticancer Fund

Repurposing of drugs for triple negative breast cancer: an overview

Andrea Spini, Sandra Donnini, Pan Pantziarka, Sergio Crispino, Marina Ziche (2020). Repurposing of drugs for triple negative breast cancer: an overview. eCancer 13 July 2020, https://doi.org/10.3332/ecancer.2020.1071

Reflection on Europe's Cancer Mission Board

Our response to the European Commission's public consultation on the Pharmaceutical Strategy Roadmap

Follow-up: Webinar on drug repurposing for cancer in the COVID-19 era

The Anticancer Fund is one of the first philanthropic organisations to join the European Cancer Community 365